Samuel Singer - Researcher Profile | RDL Research Database

Publications

3 shown

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

George D. Demetri , Margaret von Mehren , Charles D. Blanke +18 more

Imatinib induced a sustained objective response in more than half of patients with an advanced unresectable or metastatic gastrointestinal stromal tumor. Inhibition of the KIT s...

2002 New England Journal of Medicine 4336 citations

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

Michael C. Heinrich , Christopher L. Corless , George D. Demetri +15 more

Purpose: Most gastrointestinal stromal tumors (GISTs) express constitutively activated mutant isoforms of KIT or kinase platelet-derived growth factor receptor alpha (PDGFRA) th...

2003 Journal of Clinical Oncology 2275 citations

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim , Craig H. Mermel , Dale Porter +59 more

2010 Nature 3995 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 10,606
Institution: Dana-Farber Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9713-8230

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.